Skip to main content
    H

    Harvard Bioscience Inc (HBIO)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $9.08
    +0.17 (+1.91%)

    Market Cap: $40.75M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Harvard Bioscience Inc (HBIO) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Harvard Bioscience (HBIO) has a latest price of $9.08 on Nov 17, 2026, 11.0% below its 52-week high of $10.20. Its price rose 37.7% over the past 12 months. The month-end price fell 62.9% over the 10 years through Oct 2026, a compound annual decline of 9.4%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $83.30 in Jun 2021 and its lowest $3.56 in Apr 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart HBIO with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for HBIO.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 28.2%, and over 6 months it rose 81.2%. The month-end price fell 79.7% over the 3 years through Oct 2026, a compound annual decline of 41.3%.

    PeriodChange
    1 month+12.2%
    3 months+28.2%
    6 months+81.2%
    12 months+37.7%
    12 months, with dividends+37.7%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-79.7%-41.3%
    5 years-88.2%-34.8%
    10 years-62.9%-9.4%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2023, when the price rose 93.1%, and its weakest was 2025, when it fell 68.3%.

    YearCloseChange
    2026 through Oct 2026$8.90+33.1%
    2025$6.69-68.3%
    2024$21.10-60.6%
    2023$53.50+93.1%
    2022$27.70-60.7%
    2021$70.50+64.3%
    2020$42.90+40.7%
    2019$30.50-4.1%
    2018$31.80-3.6%
    2017$33.00+8.2%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 8.3% above its 50-day average of $8.38 and 36.9% above its 200-day average of $6.63.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$9.08
    52-week high$10.20-11.0%
    52-week low$4.00+127.0%
    50-day average$8.38+8.3%
    200-day average$6.63+36.9%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 94.8%.

    MeasureValue
    1-year beta1.38
    Largest fall, 1 year-45.2%
    Largest fall, 3 years-94.8%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About HBIO

    What is HBIO's 1-year price change?

    Harvard Bioscience's price rose 37.7% over the past 12 months. With dividends included, the 12-month total return was 37.7%.

    What is HBIO's 5-year price change?

    Harvard Bioscience's month-end price fell 88.2% over the 5 years through Oct 2026, a compound annual decline of 34.8%. These figures leave out dividends.

    What is HBIO's 52-week high and low?

    Harvard Bioscience's 52-week high is $10.20 and its 52-week low is $4.00. Its latest price of $9.08 on Nov 17, 2026 is 11.0% below the high.

    What is HBIO's beta?

    Harvard Bioscience's 1-year beta against the S&P 500 is 1.38, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 45.2%.

    Is the HBIO chart free?

    Yes. Advanced Charting for HBIO is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.